Practical Questions About Rescue Medications for Acute Treatment of Seizure Clusters in Children and Adolescents with Epilepsy in the USA: Expanding Treatment Options to Address Unmet Needs-Reference-Cited by-同舟云学术

Practical Questions About Rescue Medications for Acute Treatment of Seizure Clusters in Children and Adolescents with Epilepsy in the USA: Expanding Treatment Options to Address Unmet Needs

Published:2023-10-30 Issue:1 Volume:26 Page:49-57
ISSN:1174-5878
Container-title:Pediatric Drugs
language:en
Short-container-title:Pediatr Drugs

Author:

Wheless James W.^ORCID,Gidal Barry^ORCID,Rabinowicz Adrian L.^ORCID,Carrazana Enrique^ORCID

Funder

Neurelis, Inc.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pediatrics, Perinatology and Child Health

Link

https://link.springer.com/content/pdf/10.1007/s40272-023-00601-x.pdf

Reference57 articles.

1. Penovich PE, Buelow J, Steinberg K, Sirven J, Wheless J. Burden of seizure clusters on patients with epilepsy and caregivers: survey of patient, caregiver, and clinician perspectives. Neurologist. 2017;22(6):207–14. https://doi.org/10.1097/NRL.0000000000000140.

2. Cloyd J, Haut S, Carrazana E, Rabinowicz AL. Overcoming the challenges of developing an intranasal diazepam rescue therapy for the treatment of seizure clusters. Epilepsia. 2021;62(4):846–56. https://doi.org/10.1111/epi.16847.

3. Jafarpour S, Hirsch LJ, Gainza-Lein M, Kellinghaus C, Detyniecki K. Seizure cluster: definition, prevalence, consequences, and management. Seizure. 2019;68:9–15. https://doi.org/10.1016/j.seizure.2018.05.013.

4. Wirrell EC, Nabbout R, Scheffer IE, Alsaadi T, Bogacz A, French JA, et al. Methodology for classification and definition of epilepsy syndromes with list of syndromes: report of the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022;63(6):1333–48. https://doi.org/10.1111/epi.17237.

5. Bausch Health US, LLC. Diastat® C-IV (diazepam rectal gel). Full prescribing information. Bridgewater (NJ): Bausch Health US, LLC; 2023.